Source: Annual Congress 2003 - Respiratory structure and mechanisms: current concepts



Rating:

Share or cite this content

Citations should be made in the following way:
A. Tronde, B. Nordén, H. Marchner, A. K. Wendel, H. Lennernäs, U. Hultkvist Bengtsson (Lund, Sweden). Pulmonary absorption rate and bioavailability of drugs in vivo in rats: Analysis of structure-absorption relationships. Eur Respir J 2003; 22: Suppl. 45, 162

Member's Comments

No comment yet.

Related content which might interest you: Pharmacokinetic factors affecting airway selectivity of inhaled steroids – role of prodrug conversion and absorption Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 Lung absorption half-life of inhaled drugs can be predicted with rat lung slices Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Pharmacokinetic factors affecting airway selectivity of inhaled steroids - role of intracellular esterification Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001 Acute effects of cisplatin on mucociliary function: In vitro measurements Source: Annual Congress 2010 - Pathology of lung cancer Year: 2010 Interrelationship of pharmacokinetics/pharmacodynamics: antibiotic dosing for the future Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=1 Year: 2004 Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease Source: Eur Respir J 2003; 22: Suppl. 45, 474s Year: 2003 Systemic bioavailability of inhaled steroids: the importance of appropriate and comparable methodology Source: Eur Respir J 2001; 17: 157-158 Year: 2001 Pharmacokinetic interactions in different combinations of pulmonary arterial hypertension treatment Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Pulmonary and systemic inflammation in a domestic animal model of respiratory chlamydophila psittaci infection: Evaluation of dose-response relationships Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies Year: 2011 Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006 Pharmacokinetics and safety of concomitant macitentan and hormonal contraceptives Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 In-vivo lung molecular imaging of choline metabolism in a rat model of pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Measurement of pulmonary structure and function Source: Eur Respir Monogr 2015; 70: 216-232 Year: 2015 A human lung reperfusion model for monitoring the initial pulmonary absorption of drugs from aerosol devices Source: Eur Respir J 2005; 26: Suppl. 49, 125s Year: 2005 Analysis of miRNA profile in circulating microparticles of patients with pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics Source: International Congress 2015 – New models for treating airway diseases Year: 2015 Gene expression profile of pulmonary inflammation in rat lung induced by nickel oxide nanoparticles following intratracheal instillation Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Pulmonary mechanics in a mouse model of emphysema: in vivo and in vitro evaluation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Late Breaking Abstract - Spatial pharmacokinetics of inhaled drugs in human lung – evaluation of regional lung targeting by direct sampling of epithelial lining fluid Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019 Different tissue accumulation kinetics of ciclesonide-active metabolite and budesonide in mice Source: Eur Respir J 2006; 28: Suppl. 50, 433s Year: 2006